Dubois G, Mussini J M, Auclair M, Battesti J, Boutry J M, Kemeny J L, Mazière J C, Turpin J C, Hauw J J
Laboratoire de Chimie Biologique, Faculté de Médecine Saint-Antoine, Paris, France.
Neurology. 1990 Jan;40(1):132-6. doi: 10.1212/wnl.40.1.132.
We studied 2 unrelated adult patients under neuroleptic treatment who met all phenotypic and biochemical criteria for Niemann-Pick disease type B. In addition, they had chronic psychiatric disorders and low blood levels of HDL cholesterol. The marked and persistent deficiency of acid sphingomyelinase and the disturbance of sphingomyelin metabolism in skin fibroblast subcultures ruled out a pure drug-induced lipidosis. The association of Niemann-Pick disease type B with psychiatric disorders and with low levels of HDL cholesterol could be a chance association of 2 diseases, a new phenotype of Niemann-Pick type B, or the revelation by the neuroleptic treatment of a subclinical inborn sphingomyelinase deficiency.
我们研究了2名接受抗精神病药物治疗的成年患者,他们符合B型尼曼-匹克病的所有表型和生化标准。此外,他们患有慢性精神疾病且高密度脂蛋白胆固醇血液水平较低。皮肤成纤维细胞传代培养中酸性鞘磷脂酶明显且持续缺乏以及鞘磷脂代谢紊乱排除了单纯药物性脂质沉积症。B型尼曼-匹克病与精神疾病以及高密度脂蛋白胆固醇水平低之间的关联可能是两种疾病的偶然关联、B型尼曼-匹克病的一种新表型,或者是抗精神病药物治疗揭示的一种亚临床先天性鞘磷脂酶缺乏症。